TARLOXOTINIB BROMIDE

UNII:	3Y31FJ8K50
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₄H₂₄BrClN₉O₃.Br
Preferred Substance Name:	TARLOXOTINIB BROMIDE
InChIKey:	WAKIMVYUBWMMHJ-FXRZFVDSSA-N
GSRS Full Record:	3Y31FJ8K50 i

1636180-98-7
(2E)-4-((4-(3-BROMO-4-CHLOROANILINO)PYRIDO(3,4-D)PYRIMIDIN-6-YL)AMINO)-N,N-DIMETHYL-N-((1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)METHYL)-4-OXOBUT-2-EN-1-AMINIUM BROMIDE
1H-IMIDAZOLE-5-METHANAMINIUM, N-((2E)-4-((4-((3-BROMO-4-CHLOROPHENYL)AMINO)PYRIDO(3,4-D)PYRIMIDIN-6-YL)AMINO)-4-OXO-2-BUTEN-1-YL)-N,N,1-TRIMETHYL-4-NITRO-, BROMIDE (1:1)
Tarloxotinib bromide [WHO-DD]
[(E)-4-[[4-(3-bromo-4-chloroanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]-4-oxobut-2-enyl]-dimethyl-[(3-methyl-5-nitroimidazol-4-yl)methyl]azanium bromide
tarloxotinib bromide [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TARLOXOTINIB BROMIDE

Synonyms and Mappings

Resources